| Hans-Günter Meyer-Thompson | Fachveröffentlichungen
FDA. New Recommendations for Naloxone (2020)
FDA. New Recommendations for Naloxone (2020)
To reduce the risk of death from opioid overdose, the U.S. Food and Drug Administration has made the following recommendations about the opioid reversal medicine, naloxone. (US Food and Drug Administration, 23.07.2020)
https://www.fda.gov/drugs/drug-safety-and-availability/new-recommendations-naloxone